Infiniwell BPC-157
OvationLab and InfiniWell have established a strategic partnership to advance the clinical application of BPC-157, a peptide known for its regenerative properties. This collaboration focuses on enhancing the understanding and utilization of BPC-157 in functional and integrative medicine.
Clinical Research and Product Development
OvationLab conducted a landmark human study assessing the safety and efficacy of BPC-157 in adults with chronic pain. This research provided valuable insights into the peptide’s potential benefits for musculoskeletal and gastrointestinal health .
InfiniWell offers a range of BPC-157 formulations, including Rapid and Delayed Release capsules, designed to support joint, muscle, and gut health. These products incorporate Salcaprozate Sodium (SNAC) to enhance oral bioavailability, addressing the traditional challenges of peptide absorption.
Practitioner Education and Protocol Integration
The partnership emphasizes practitioner education through webinars, workshops, and the development of clinical protocols. By integrating BPC-157 into treatment plans, healthcare providers can offer targeted support for tissue repair, inflammation reduction, and gut-brain axis optimization.
Advancing Whole-Person Health
Together, OvationLab and InfiniWell contribute to the advancement of whole-person health by providing evidence-based solutions that align with the principles of functional and integrative medicine. Their collaborative efforts aim to enhance patient outcomes through innovative therapies and comprehensive practitioner support.
Pages
Connect
© 2025 OvationLab